Pulse Biosciences, Inc. (PLSE) Operating income 2016–2025
Pulse Biosciences, Inc. (PLSE) annual operating income history from SEC filings — each fiscal year as reported.
-$76.9MFY2025 · since FY2016: -$9.5M → -$76.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$76.9M | -36.8% |
| FY2024 | -$56.3M | -29.1% |
| FY2023 | -$43.6M | +24.9% |
| FY2022 | -$58.1M | +7.9% |
| FY2021 | -$63.0M | -26.1% |
| FY2020 | -$50.0M | -4.2% |
| FY2019 | -$48.0M | -27.7% |
| FY2018 | -$37.5M | -46.8% |
| FY2017 | -$25.6M | -168.6% |
| FY2016 | -$9.5M | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More PLSE financial trends
PLSE RevenuePLSE Net incomePLSE Net marginPLSE Gross profitPLSE Gross marginPLSE Operating marginPLSE Operating cash flowPLSE Free cash flowPLSE Capital expendituresPLSE Return on equityPLSE Stock buybacksPLSE Dividends paidPLSE Total assetsPLSE Total liabilitiesPLSE Shareholders’ equityPLSE overview →